Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 50 | +13 |
| Shares | 1.83M | 33 | 2.48M | +642.7K (+35.1%) |
| Value | $9.37M | $0 | $11.9M | +$2.54M (+27.1%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 57,700 | $278.0K | 0.00% |
| Two Sigma Investments, LP | 57,218 | $275.0K | 0.00% |
| Millennium Management LLC | 33,140 | $159.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 31,484 | $151.0K | 0.00% |
| Two Sigma Advisers, LP | 25,416 | $122.0K | 0.00% |
| Intrepid Financial Planning Group LLC | 20,000 | $96.0K | 0.05% |
| Qube Research & Technologies Ltd | 19,037 | $92.0K | 0.00% |
| Delphia (USA) Inc. | 17,669 | $85.0K | 0.06% |
| Corton Capital Inc. | 16,285 | $78.0K | 0.07% |
| Two Sigma Securities, LLC | 12,624 | $61.0K | 0.01% |
| Perritt Capital Management Inc | 12,000 | $58.0K | 0.04% |
| Leonteq Securities AG | 8,000 | $39.5K | 0.00% |
| Credit Suisse AG | 1 | $0 | 0.00% |
| Trust Co of Vermont | 50 | $0 | 0.00% |
| UBS Group AG | 36 | $0 | 0.00% |
| Steward Partners Investment Advisory, LLC | 100 | $0 | 0.00% |
| Truvestments Capital LLC | 60 | $0 | 0.00% |
Sold out (4)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Simplex Trading, LLC | 19,413 | $99.0K |
| ACT Capital Management, LLC | 6,500 | $33.0K |
| Royal Bank of Canada | 406 | $2.00K |
| Glassman Wealth Services | 1 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Dixon Hughes Goodman Wealth Advisors LLC | 33 | $0 |